The Ahmed versus Baerveldt Study at King Khaled Eye Specialist Hospital: Three-Year Treatment Outcomes.

IF 0.5 Q4 OPHTHALMOLOGY Middle East African Journal of Ophthalmology Pub Date : 2021-12-31 eCollection Date: 2021-07-01 DOI:10.4103/meajo.meajo_89_21

Nouf Abdulkalq Alzendi, Sami Alshahwan, Areej Alwehaib, Khawlah Alzaben, Sara Alhilali, Abeer Alkahtani

{"title":"The Ahmed versus Baerveldt Study at King Khaled Eye Specialist Hospital: Three-Year Treatment Outcomes.","authors":"Nouf Abdulkalq Alzendi, Sami Alshahwan, Areej Alwehaib, Khawlah Alzaben, Sara Alhilali, Abeer Alkahtani","doi":"10.4103/meajo.meajo_89_21","DOIUrl":null,"url":null,"abstract":"Purpose: The purpose of this study was to analyze the outcomes of two frequently used surgical valves in treating refractory glaucoma.Methods: This was a retrospective and nonrandomized study comparing patients aged 18 years or older who underwent implantation using standardized surgical techniques.Results: A total of 86 patients were included in the study, 48 in the Ahmed group and 38 in the Baerveldt group. The overall success rate was 63.1% in both the groups. At the 3-year follow-up, the Ahmed group had a mean intraocular pressure (IOP) of 14.0 ± 4.8 mmHg (60% reduction) compared with 15.8 ± 6.2 mmHg (53.3% reduction) in the Baerveldt group (0.536). The Ahmed group required an average of 1.6 ± 1.3 medications (59% reduction) compared with 2.1 ± 1.7 (40% reduction) in the Baerveldt group (P < 0.001).Conclusion: Despite a high failure rate, both devices were effective in lowering IOP and the need for medications. Lower IOP and medications were needed in the Ahmed group.","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"28 3","pages":"143-150"},"PeriodicalIF":0.5000,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763102/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Middle East African Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/meajo.meajo_89_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: The purpose of this study was to analyze the outcomes of two frequently used surgical valves in treating refractory glaucoma.

Methods: This was a retrospective and nonrandomized study comparing patients aged 18 years or older who underwent implantation using standardized surgical techniques.

Results: A total of 86 patients were included in the study, 48 in the Ahmed group and 38 in the Baerveldt group. The overall success rate was 63.1% in both the groups. At the 3-year follow-up, the Ahmed group had a mean intraocular pressure (IOP) of 14.0 ± 4.8 mmHg (60% reduction) compared with 15.8 ± 6.2 mmHg (53.3% reduction) in the Baerveldt group (0.536). The Ahmed group required an average of 1.6 ± 1.3 medications (59% reduction) compared with 2.1 ± 1.7 (40% reduction) in the Baerveldt group (P < 0.001).

Conclusion: Despite a high failure rate, both devices were effective in lowering IOP and the need for medications. Lower IOP and medications were needed in the Ahmed group.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

哈立德国王眼科专科医院的Ahmed与Baerveldt研究:三年治疗结果

目的:本研究的目的是分析两种常用的手术瓣膜治疗难治性青光眼的结果。方法:这是一项回顾性和非随机研究，比较了18岁及以上采用标准化手术技术进行植入术的患者。结果:共有86例患者纳入研究，其中Ahmed组48例，Baerveldt组38例。两组的总成功率均为63.1%。在3年的随访中，Ahmed组的平均眼压(IOP)为14.0±4.8 mmHg(降低60%)，Baerveldt组为15.8±6.2 mmHg(降低53.3%)(0.536)。Ahmed组平均用药次数为1.6±1.3次(减少59%)，Baerveldt组为2.1±1.7次(减少40%)(P < 0.001)。结论:尽管失败率很高，但这两种装置在降低IOP和药物需求方面都是有效的。艾哈迈德组需要降低IOP和药物治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Middle East African Journal of Ophthalmology OPHTHALMOLOGY-

CiteScore

1.40

自引率

0.00%

发文量

期刊介绍： The Middle East African Journal of Ophthalmology (MEAJO), published four times per year in print and online, is an official journal of the Middle East African Council of Ophthalmology (MEACO). It is an international, peer-reviewed journal whose mission includes publication of original research of interest to ophthalmologists in the Middle East and Africa, and to provide readers with high quality educational review articles from world-renown experts. MEAJO, previously known as Middle East Journal of Ophthalmology (MEJO) was founded by Dr Akef El Maghraby in 1993.